"INTEGRIS Cancer Institute offers one of the foremost collections of physicians along with state-of-the-art comprehensive therapies for the diagnosis, treatment and survivorship of cancer patients. We offer 200,000 square foot facility includes radiation oncology, imaging, infusion therapy, a wellness center, a meditation garden and a medical office building. Call for more information."

During the past decade, Integris Cancer Institute of Oklahoma conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 17 clinical trials were completed, i.e. on average, 68% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 11 clinical trials were completed. i.e. 137.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Integris Cancer Institute of Oklahoma" #1 sponsor was "National Cancer Institute (NCI)" with 22 trials, followed by "Alliance for Clinical Trials in Oncology" with 10 trials sponsored, "Radiation Therapy Oncology Group" with 2 trials sponsored, "SWOG Cancer Research Network" with 2 trials sponsored and "Calithera Biosciences, Inc" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Integris Cancer Institute of Oklahoma" #1 collaborator was "National Cancer Institute (NCI)" with 17 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "American College of Surgeons" with 1 trials as a collaborator and "Daiichi Sankyo, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Integris Cancer Institute of Oklahoma" are "Colorectal Cancer" (7 trials), "Recurrent Breast Carcinoma" (3 trials), "Stage IIIB Lung Cancer AJCC v8" (3 trials), "Triple-Negative Breast Carcinoma" (3 trials) and "Breast Cancer" (2 trials). Many other conditions were trialed in "Integris Cancer Institute of Oklahoma" in a lesser frequency.

Most popular intervention types in "Integris Cancer Institute of Oklahoma" are "Drug" (36 trials), "Other" (23 trials), "Biological" (18 trials), "Procedure" (12 trials) and "Radiation" (9 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (14 trials), "Paclitaxel" (7 trials), "Quality-of-Life Assessment" (7 trials), "Carboplatin" (6 trials) and "Computed Tomography" (6 trials). Other intervention names were less common.

The vast majority of trials in "Integris Cancer Institute of Oklahoma" are 40 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Integris Cancer Institute of Oklahoma". undefined are not yet recruiting, 10 are recruiting, 23 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Integris Cancer Institute of Oklahoma, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Integris Cancer Institute of Oklahoma, 0 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".